SACCATOSIDE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 4eEdYaZ72ue |
|---|---|
| InChI | InChI=1S/C30H38O16/c1-12-19(35)22(38)25(43-17(34)7-4-13-2-5-14(33)6-3-13)29(41-12)44-24-15-8-9-40-27(18(15)30(11-32)26(24)46-30)45-28-23(39)21(37)20(36)16(10-31)42-28/h2-9,12,15-16,18-29,31-33,35-39H,10-11H2,1H3/b7-4+/t12-,15-,16-,18-,19-,20-,21+,22+,23-,24+,25+,26+,27+,28+,29-,30-/m1/s1 |
| InChIKey | XIPQZLUSSJDAIC-KICFSBEZSA-N |
| Mol Weight | 654.6 g/mol |
| Molecular Formula | C30H38O16 |
| Exact Mass | 654.215985 g/mol |
| Enantiomer InChIKey | XIPQZLUSSJDAIC-FFLJQJFVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
Methyl 1-(Glucopyranosyloxy)-4a,7a-dihydro-4'-(1-hydroxyethyl)-5'oxo-1H,5'H-spiro[cyclopenta[c]pyran-7,2'-furan]-4-carboxylate
10-METHOXYCARBONYL-HASTATOSIDE
PICCONIOSIDE-I-OCTAACETATE
#1;CALYSOLIN-XIV;11S-JALAPINOLIC-ACID-11-O-BETA-D-GLUCOPYRANOSYL-(1->3)-O-(2-O-2S,3S-NILOYL-4-O-TIGLOYL)-ALPHA-L-RHAMNOPYRANOSYL-(1->2)-[O-BETA-D-GLUCOPYRANOSY
1,2-O-Isopropylidene-3-O-(m-methylbenzyl)-4,5-O-[(1'R)-trans-3'-phenyl-2'-propen-1'-yl]-.beta.-D-fluctopyranose
7-FERULOYLLOGANIN_PERACETATE
11-(4-cyclohexylanilino)-2,3-dihydro-1H-cyclopenta[4,5]pyrido[1,2-a]benzimidazole-4-carbonitrile
{[(3S,4S,7R,8S)-1-OXO-3,7-DIMETHYL-4-(O-BETA-D-GLUCOPYRANOSYL)-OXY]-HEXAHYDROCYCLOPENTA-[C]-FURAN-3-YL}-METHYL-TRANS-4-HYDROXYCINNAMATE
HYPOLAETIN-7-O-[6'''-O-ACETYL-BETA-D-ALLOPYRANOSYL-(1->2)]-BETA-D-GLUCOPYRANOSIDE
Opulus iridoid iv
| Title | Journal or Book | Year |
|---|---|---|
| Anti-Inflammatory Activity Comparison among Scropoliosides—Catalpol Derivatives with 6-O-Substituted Cinnamyl Moieties | Molecules | 2015 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.